Account
Watchlists
Bookmarks
Pricing
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2025
Bearish
5
Neutral
3
Bullish
6
Bearish
37
Neutral
3
Bullish
6
Bearish
32
Neutral
0
Bullish
0
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Market Cap
₹ 60 Cr
P/E
8.28
Shelter Pharma Limited, originally Shelter Pharmacy, is a manufacturer of ayurvedic and herbal products with a strong presence in the Human and Veterinary Pharma sectors.
Originally a local business in Himmatnagar, it expanded throughout Gujarat, leveraging in-house R&D for product portfolio enhancement.
Recently, Shelter Pharma underwent organizational restructuring, invested in manufacturing capacity, and sourced raw materials directly from nearby farmers.
Its recent IPO raised approximately Rs 16.02 Crore, indicating robust investor confidence for expansion plans.
The company is continuing its expansion strategically, leveraging a strong product portfolio and focused marketing to capture opportunities in both human and veterinary markets.
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs
60 Cr
Moderate Risk
8.3
59.2
0.2
1.0
69.70
35.70
Sales CAGR
1Y
26.59%
3Y
19.01%
5Y
11.00%
10Y
—
Profit CAGR
1Y
16.77%
3Y
52.05%
5Y
146.02%
10Y
—
ROE
TTM
13.52%
3Y
20.03%
5Y
19.03%
10Y
—
ROCE
TTM
17.90%
3Y
26.36%
5Y
25.08%
10Y
—
Performance
STEADY PERFORMER
Valuation
UNDERVALUED
Growth
STABLE
Profitability
HIGH MARGIN
Technicals
Bearish
Risk
MODERATE RISK
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
253.80 | 78 Cr | 49.94 | 1.11 | 0.39 | 2.22 | 4.92 | 1.19 | |
85.00 | 72 Cr | 18.97 | 1.87 | 0.00 | 0.00 | 0.00 | 4.00 | |
38.90 | 60 Cr | 8.28 | 1.03 | 0.00 | 13.52 | 17.90 | 12.26 | |
37.01 | 56 Cr | 88.52 | 2.09 | 0.00 | 2.42 | 3.29 | 2.41 | |
74.30 | 54 Cr | 12.38 | 1.24 | 0.00 | 8.16 | 7.47 | 2.28 | |
49.62 | 37 Cr | 19.33 | 2.04 | 0.00 | 10.56 | 10.48 | 2.22 | |
18.95 | 28 Cr | 124.38 | 1.20 | 0.00 | 1.08 | 3.59 | 1.00 |
Order Award
9 hours ago
Shelter Pharma Secures Order from Taha Drugs
Shelter Pharma Limited has secured an international order worth $27,540 from Taha Drugs & Chemicals Co. Ltd for D3 Cure Capsules.
Press Release
1 day ago
Launch of D3 Cure Capsules by Shelter Pharma Limited
Shelter Pharma Limited announces the launch of D3 Cure Capsules aimed at preventing and treating vitamin D deficiency, part of its strategy to expand in the Nutraceutical market.
Order Award
4 days ago
Shelter Pharma Secures Order from Taha Drugs
Shelter Pharma Limited has secured an order worth $27,600 from Taha Drugs & Chemicals Co. Ltd for Joemega Capsules.
